تخطي إلى المحتوى الرئيسي

mitogen-activated protein kinase kinase 2

ال MAP2K2 gene provides instructions for making a protein known as MEK2 protein kinase. This protein is part of a signaling pathway called the RAS/MAPK pathway, which transmits chemical signals from outside the cell to the cell's nucleus. RAS/MAPK signaling helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement, and the self-destruction of cells (apoptosis).

اختيارات الفيديو لـ Genes
مكتبة الفيديو

Normal function

ال MAP2K2 gene provides instructions for making a protein known as MEK2 protein kinase. This protein is part of a signaling pathway called the RAS/MAPK pathway, which transmits chemical signals from outside the cell to the cell's nucleus. RAS/MAPK signaling helps control the growth and division (proliferation) of cells, the process by which cells mature to carry out specific functions (differentiation), cell movement, and the self-destruction of cells (apoptosis).

ال MAP2K2 gene is very similar to a gene called MAP2K1, which provides instructions for making a protein known as MEK1 protein kinase. Like MEK2 protein kinase, this protein functions as part of the RAS/MAPK signaling pathway. Together, the MEK1 and MEK2 protein kinases appear to be essential for normal development before birth and for survival after birth.

Conditions referring to this gene or chromosome

Other names

dual specificity mitogen-activated protein kinase kinase 2

ERK activator kinase 2

MAP kinase kinase 2

MAPK-ERK Kinase 2

MAPK/ERK kinase 2

MAPKK2

MEK2

mitogen-activated protein kinase kinase 2, p45

MKK2

MP2K2_HUMAN

PRKMK2

Related patient information and medicines

التليف النقوي

Patient information leaflet

التليف النقوي

التليف النقوي which develops as a complication of other diseases is called secondary myelofibrosis. Myelofibrosis is caused by an abnormality of the developing cells (stem cells) in the bone marrow. It's not known what causes the genetic mutation in blood stem cells. The gene mutation that occurs in most people affected by myelofibrosis is a.

ضمور العضلات

Patient information leaflet

ضمور العضلات

ضمور العضلات هو inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. Also, if a child has delayed motor mil... MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

التهاب المفاصل اليفعي مجهول السبب

Patient information leaflet

التهاب المفاصل اليفعي مجهول السبب

As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if.

سرطان الكبد الأولي

Patient information leaflet

سرطان الكبد الأولي

If you already have cirrhosis and your health becomes worse quite quickly, the cause may be a liver السرطان which has developed. Everyone with cirrhosis should be having regular monitoring with an ultrasound and blood tests to detect any development of a liver cancer. There are new medicines being developed for the treatment of liver cancer. For.

سرطان الفم

Patient information leaflet

سرطان الفم

Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a تشخيص or ruling out of cancer within 28 days of being.

داء الخلايا البدينة واضطرابات الخلايا البدينة

Patient information leaflet

داء الخلايا البدينة واضطرابات الخلايا البدينة

A mast cell هو a type of white blood cell. If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (suc... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

قراءة إضافية ومراجع

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 18 Aug 2020 | أحدث إصدار
  • 1 May 2012 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

صيدلية إلكترونية وعلاجات وخدمات صحية

وصول بسيط إلى العلاجات والخدمات الصحية الموثوقة عبر الإنترنت.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.